| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Wellcome Surgical Institute and 2 Department of Medicine and Therapeutics, University of Glasgow, Glasgow G61 1QH, United Kingdom
Estrogen treatment has been shown to reduce ischemic brain damage. Because endogenous estrogen levels fluctuate markedly during the estrous cycle, we investigated the effect of stage of estrous cycle on ischemic brain damage. Halothane anesthetized 3- to 5-mo-old female Wistar-Kyoto rats (WKY) and stroke-prone spontaneously hypertensive rats (SHRSP) in proestrus (high estradiol levels) or metestrus (low estradiol levels) underwent permanent middle cerebral artery occlusion. In SHRSP, infarct volume at 24 h postocclusion was 24% smaller in proestrus compared with metestrus [208.6 ± 9.5 mm3 (n = 7) vs. 272.7 ± 23.8 mm3 (n = 7), respectively, means ± SE; P = 0.0278, unpaired t-test]. In WKY, infarct volumes were similar in proestrus and metestrus [157.0 ± 5.4 mm3 (n = 5) and 131.5 ± 16.5 mm3 (n = 8), respectively; P = not significant (NS)]. Brain swelling (ipsilateral minus contralateral hemispheric volumes) was similar in proestrus and metestrus for SHRSP [138 ± 9 mm3 (n = 6) and 136 ± 10 mm3 (n = 7), respectively] and for WKY [103 ± 15 mm3 (n = 5) and 90 ± 11 mm3 (n = 8), respectively]. Thus the reduction in infarct size in SHRSP is caused by a true attenuation of the infarct volume and not simply by a reduction in brain edema.
middle cerebral artery occlusion; brain damage
This article has been cited by other articles:
|
|
 |
|
  S. J. Spencer, M. A. Galic, M. Tsutsui, Q. J. Pittman, and A. Mouihate Effects of Global Cerebral Ischemia in the Pregnant Rat Stroke, March 1, 2008; 39(3): 975 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Spencer, A. Mouihate, M. A. Galic, and Q. J. Pittman Central and peripheral neuroimmune responses: hyporesponsiveness during pregnancy J. Physiol., January 15, 2008; 586(2): 399 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Rigsby, A. E. Burch, S. Ogbi, D. M. Pollock, and A. M. Dorrance Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1754 - R1763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Simpkins, S.-H. Yang, R. Liu, E. Perez, Z. Y. Cai, D. F. Covey, and P. S. Green Estrogen-Like Compounds for Ischemic Neuroprotection Stroke, November 1, 2004; 35(11_suppl_1): 2648 - 2651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.V.O. Carswell, I.M. Macrae, L. Gallagher, E. Harrop, and K.J. Horsburgh Neuroprotection by a selective estrogen receptor {beta} agonist in a mouse model of global ischemia Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1501 - H1504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-H. YANG, R. LIU, S. S. WU, and J. W. SIMPKINS The Use of Estrogens and Related Compounds in the Treatment of Damage from Cerebral Ischemia Ann. N.Y. Acad. Sci., December 1, 2003; 1007(1): 101 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. McCullough, K. Blizzard, E. R. Simpson, O. K. Oz, and P. D. Hurn Aromatase Cytochrome P450 and Extragonadal Estrogen Play a Role in Ischemic Neuroprotection J. Neurosci., September 24, 2003; 23(25): 8701 - 8705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Stier Jr., P. N. Chander, L. Rosenfeld, and C. A. Powers Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E232 - E239. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
